Organization (Academic)
Mardin Artuklu University
ClinicalTrials.gov lists Mardin Artuklu University as lead sponsor of 26 trials. It has 5 active development programs.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 6 registered with a 2026 start date. The dashed outline is the pace from the 6 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 3.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Mardin Artuklu University, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Mardin Artuklu University: 26 lead-sponsored trials and 1 legal-entity registration.
Disease areas (24)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 5 |
| Sleep Initiation and Maintenance Disorders | 3 |
| Abdominal Pain | 2 |
| Anxiety Disorders | 2 |
| Disorders of Excessive Somnolence | 2 |
Showing 5 of 24 disease areas.
Trials by start year as sponsor or collaborator (9)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 6 |
| 2025 | 8 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 6 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 1 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (5)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Control (placebo) group | Irritable Bowel Syndrome | Not reported | 1 |
| Aerobic exercise | Migraine Disorders | Not reported | 1 |
| Intervention Group | Irritable Bowel Syndrome | Not reported | 1 |
| Maltodextrin | Constipation | Not reported | 1 |
| Maltodextrin | Irritable Bowel Syndrome | Not reported | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 3 hit target (n=3) | 3 of 3 on time (n=3) |
Journals published in (16)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Acta oncologica (Stockholm, Sweden) | 1 |
| Best practice & research. Clinical gastroenterology | 1 |
| Clinical and experimental otorhinolaryngology | 1 |
| Clinical autonomic research : official journal of the Clinical Autonomic Research Society | 1 |
| Diagnostics (Basel, Switzerland) | 1 |
Showing 5 of 16 journals.
Latest dated events (27)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-08-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 27 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| NADK | Trial sponsor | Named in trial inclusion criteria |
| NADK | Trial sponsor | Mentioned in trial text |
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.